BE

Bernd Eidenmueller

AG Aventis Pharma Deutschland Gmbh: 1 patents #209 of 418Top 50%
Hoechst Gmbh: 1 patents #2,248 of 4,020Top 60%
Overall (All Time): #2,222,337 of 4,157,543Top 55%
2
Patents All Time

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems Eckart Bartnik, Frank Buettner, Bruce Caterson, Clare Hughes 2001-01-30
5872209 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems Eckart Bartnik, Frank Buettner, Bruce Caterson, Clare Hughes 1999-02-16